(Philadelphia,
PA) - Edward S. Brodkin, MD, has been appointed
an Assistant Professor in the Department of Psychiatry
at the University of Pennsylvania School of Medicine.
Dr. Brodkin attended Harvard University, where he received
his AB degree magna cum laude in the History of Science.
He went on to earn his MD from Harvard Medical School
in 1992. He completed his internship in pediatrics and
residency in psychiatry, both at Yale University School
of Medicine. Following his residency training, he was
a postdoctoral research fellow at in the Department
of Psychiatry at Yale University School of Medicine
and in the Department of Molecular Biology at Princeton
University.
Among his clinical positions, Dr. Brodkin was a psychiatrist
in the Adult Autism Clinic at Yale University School
of Medicine; Staff Psychiatrist at the Schizophrenia
Clinic of West Haven VA Medical Center at Yale University
School of Medicine; and Psychiatrist in Yale's Longterm
Psychotherapy Program. Currently, he is an Attending
Psychiatrist at the Hospital of the University of Pennsylvania.
He is a member of many professional societies including
the American Association for the Advancement of Science,
American Psychiatric Association, International Mammalian
Genome Society and the Society for Neuroscience. He
is also a diplomate of the National Board of Medical
Examiners and the American Board of Psychiatry and Neurology.
Dr. Brodkin has received numerous honors and awards
including election to Phi Beta Kappa from Harvard University,
the Leadership Award for Residents from the American
Academy of Child and Adolescent Psychiatry, the National
Research Service Award from the National Institutes
of Mental Health, and the Burroughs Wellcome Fund Career
Award in the Biomedical Sciences. His work on psychiatric
genetics and the biology of social behaviors has been
published in peer-reviewed journals including the Journal
of Child and Adolescent Psychopharmacology, Neuroscience,
Journal of Neuroscience, Science, and Molecular
Psychiatry.
He is married to Stephanie Heck, MS.
# # #
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.